Gtaexs617
Breast Carcinoma
Explore 209 assets in Breast Carcinoma →Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.UNKNOWNPhase 1/2
—
Rating in progress
Gtaexs617 in Breast Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active